We are live on ! Find out more
PHVS icon

Pharvaris

22 hedge funds and large institutions have $397M invested in Pharvaris in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $321M → $397M (+$76M)

0.12% more ownership

Funds ownership: 65.34%65.46% (+0.12%)

0% more funds holding

Funds holding: 2222 (0)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

Holders
22
Holders Change
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
1
Increased
5
Reduced
8
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$62M +$354K +20,079 +0.6%
FCMI
2
Foresite Capital Management IV
California
$59.2M
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$57.7M
Viking Global Investors
4
Viking Global Investors
Connecticut
$46.4M +$437K +24,783 +1%
GA
5
General Atlantic
New York
$43.9M
VP
6
venBio Partners
California
$41.8M
DM
7
Deerfield Management
New York
$28.6M -$75K -4,253 -0.3%
SCM
8
Suvretta Capital Management
New York
$15M
CAM
9
Cormorant Asset Management
Massachusetts
$12.4M -$85.4K -4,843 -0.7%
PAMS
10
Pictet Asset Management (Switzerland)
Switzerland
$10.1M -$56.1K -3,181 -0.6%
NHAS
11
Novo Holdings A/S
Denmark
$9.37M
EAM
12
Eventide Asset Management
Massachusetts
$5.66M +$1.02M +57,694 +24%
Millennium Management
13
Millennium Management
New York
$2.03M -$197K -11,172 -9%
Goldman Sachs
14
Goldman Sachs
New York
$1.01M -$29.6K -1,680 -3%
DCM
15
DAFNA Capital Management
California
$628K -$37.1K -2,105 -6%
FCMV
16
Foresite Capital Management V
California
$619K
Geode Capital Management
17
Geode Capital Management
Massachusetts
$348K
Morgan Stanley
18
Morgan Stanley
New York
$294K -$36.5K -2,071 -11%
Bank of America
19
Bank of America
North Carolina
$105K +$92.9K +5,272 +1,054%
JP Morgan Chase
20
JP Morgan Chase
New York
$64K -$239K -13,535 -80%
UBS Group
21
UBS Group
Switzerland
$13K +$5.38K +305 +72%
TRCT
22
Tower Research Capital (TRC)
New York
$1K +$1.36K +77 New
PA
23
Perceptive Advisors
New York
-$389K -27,000 Closed

PHVS Hedge Fund Activity: Q1 2022 in Review

22 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q1 2022, worth a combined $397M — up 24% from $321M a quarter earlier.

Fund positioning in PHVS was balanced in Q1 2022: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 8 trimmed.

The largest buyer was Eventide Asset Management, adding an estimated $1.02M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $389K sold.

  • 22 institutional investors held Pharvaris (PHVS) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $397M of Pharvaris stock for Q1 2022, up 24% quarter-over-quarter.
  • 1 fund opened new Pharvaris positions in Q1 2022 and 1 closed out, a net change of 0 holders.
  • The largest Pharvaris buyer in Q1 2022 was Eventide Asset Management, an estimated $1.02M added.
  • The largest Pharvaris seller in Q1 2022 was Perceptive Advisors, an estimated $389K sold.

Based on aggregated 13F filings for Q1 2022.